Related Experiment Video
Updated: Jun 24, 2026

Intravascular Delivery of Biologics to the Rat Kidney
Published on: September 1, 2016
Buprenorphine: a review
1UT Southwestern Medical Center, Dallas, Texas, USA.
Abstract:
A significant breakthrough in the treatment of opioid addiction occurred with the passage of the Data Addiction Treatment Act of 2000 (DATA 2000), signed into law by President Clinton, which allowed physicians for the first time in more than eight decades to prescribe opioid medications for the treatment of opioid addiction in the normal course of their practice. Two years later, on October 8, 2002, Suboxone (Buprenorphine/Naloxone) and Subutex (Buprenorphine) received FDA approval for the treatment of opioid addiction. Prior to DATA 2000, opioid maintenance treatment was available through highly regulated methadone clinics. This article discusses opioid addiction in the United States today and the principles of buprenorphine therapy.
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Receptors: Overview
Analgesia and Pain Management
Opioid Analgesics: Morphine and Other Natural Cogeners
Oral Drug Delivery Systems: Continuous-Release Systems
Drug Abuse and Addiction: Pharmacological Phenomena

